Sivilotti Marco L A, Filbin Michael R, Murray Heather E, Slasor Peter, Walls Ron M
Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Acad Emerg Med. 2003 Jun;10(6):612-20. doi: 10.1111/j.1553-2712.2003.tb00044.x.
To ascertain whether the sedative agent administered during neuromuscular-blocking agent-facilitated intubation (rapid sequence intubation [RSI]) influences the number of attempts and overall success at RSI.
Records were drawn from an ongoing, prospective multicenter registry of emergency department intubations. Conditional logistic regression stratified by institution was used to identify factors associated with multiple intubation attempts and unsuccessful RSI.
Of 3,407 intubations over 33 months in 22 institutions, 2,380 involved RSI. After correcting for the specialty and experience of the intubator and for the presence of airway aberrancy, the sedative agent was significantly associated with the number of attempts at intubation (p = 0.002). Specifically, the use of etomidate (adjusted odds ratio [OR] 0.35 [95% CI = 0.17 to 0.72]), ketamine (OR 0.27 [95% CI = 0.11 to 0.65]), a benzodiazepine (OR 0.47 [95% CI = 0.23 to 0.95]), or no sedative agent (OR 0.51 [95% CI = 0.23 to 1.13]) prior to neuromuscular blockade was associated with a lower likelihood of successful intubation on the first attempt, as compared with thiopental, methohexital, or propofol. The adjusted odds ratios for the likelihood of overall success had similar point estimates, but did not reach statistical significance due to lack of power (p = 0.2, with 36 unsuccessful intubations). Among patients receiving etomidate, intubation was more likely to be successful on the first attempt with increasing doses of either etomidate or succinylcholine.
Thiopental, methohexital, and propofol appear to facilitate RSI in emergency department patients, independent of patient characteristics or intubator training. A deeper plane of anesthesia may improve intubating conditions in emergency patients undergoing RSI by complementing incomplete muscle paralysis.
确定在神经肌肉阻滞剂辅助插管(快速顺序插管[RSI])过程中使用的镇静剂是否会影响RSI的尝试次数和总体成功率。
数据来自一个正在进行的前瞻性多中心急诊科插管登记处。采用按机构分层的条件逻辑回归分析来确定与多次插管尝试和RSI失败相关的因素。
在22个机构33个月内的3407次插管中,2380次涉及RSI。在校正插管者的专业和经验以及气道异常情况后,镇静剂与插管尝试次数显著相关(p = 0.002)。具体而言,与硫喷妥钠、美索比妥或丙泊酚相比,在神经肌肉阻滞前使用依托咪酯(调整后的优势比[OR]为0.35[95%可信区间(CI)= 0.17至0.72])、氯胺酮(OR为0.27[95%CI = 0.11至0.65])、苯二氮䓬类药物(OR为0.47[95%CI = 0.23至0.95])或不使用镇静剂(OR为0.51[95%CI = 0.23至1.13])与首次插管成功的可能性较低相关。总体成功可能性的调整后优势比具有相似的点估计值,但由于检验效能不足未达到统计学显著性(p = 0.2,36次插管失败)。在接受依托咪酯的患者中,随着依托咪酯或琥珀酰胆碱剂量增加,首次插管更有可能成功。
硫喷妥钠、美索比妥和丙泊酚似乎有助于急诊科患者进行RSI,与患者特征或插管者培训无关。较深的麻醉平面可能通过补充不完全的肌肉麻痹来改善接受RSI的急诊患者的插管条件。